Sarchi Christopher
SEC CIK 1986597 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| REPL | Replimune Group, Inc. | Chief Commercial Off | 181.0K | — | $412.2K | 12 | 2023-11-16 | 2026-06-01 |
Most active insiders at REPL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Patel Sushil | CEO, Dir | — | $811.2K |
| 2 | Hill Emily Luisa | CFO | — | $320.3K |
| 3 | Xynos Konstantinos | Chief Medical Off | — | $285.7K |
| 4 | Sarchi Christopher | Chief Commercial Off | — | $254.2K |
| 5 | Schwendenman Andrew | CAO | — | $139.1K |
| 6 | Astley-Sparke Philip | Dir | — | $89.7K |
| 7 | Dhingra Kapil | Dir | — | $33.0K |
Transactions 12
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-06-03 20:30 | 2026-06-01 | REPL | Replimune Group, Inc. | Sarchi Christopher | Chief Commercial Off | S - Sale | $9.24 | -12.0K | 181.0K | -6% | -$110.9K |
| 2026-05-20 16:16 | 2026-05-18 | REPL | Replimune Group, Inc. | Sarchi Christopher | Chief Commercial Off | S - Sale | $5.08 | -8,626 | 193.0K | -4% | -$43.8K | |
| D | 2026-04-07 21:11 | 2026-04-01 | REPL | Replimune Group, Inc. | Sarchi Christopher | Chief Commercial Off | A - Grant | $0.00 | +50.0K | 201.6K | +33% | $0 |
| T | 2026-04-06 16:30 | 2026-04-02 | REPL | Replimune Group, Inc. | Sarchi Christopher | Chief Commercial Off | S - Sale | $8.01 | -6,500 | 151.6K | -4% | -$52.1K |
| 2025-12-19 | 2025-12-19 | REPL | Replimune Group, Inc. | Sarchi Christopher | Chief Commercial Off | A - Grant | $0.00 | +35.0K | 158.1K | +28% | $0 | |
| 2025-11-19 | 2025-11-17 | REPL | Replimune Group, Inc. | Sarchi Christopher | Chief Commercial Off | S - Sale | $9.10 | -5,208 | 123.1K | -4% | -$47.4K | |
| 2025-05-22 | 2025-05-20 | REPL | Replimune Group, Inc. | Sarchi Christopher | Chief Commercial Off | S - Sale | $8.05 | -3,749 | 128.3K | -3% | -$30.2K | |
| D | 2025-04-03 | 2025-04-01 | REPL | Replimune Group, Inc. | Sarchi Christopher | Chief Commercial Off | A - Grant | $0.00 | +45.0K | 132.0K | +52% | $0 |
| 2024-11-20 | 2024-11-18 | REPL | Replimune Group, Inc. | Sarchi Christopher | Chief Commercial Off | S - Sale | $10.78 | -5,207 | 87.0K | -6% | -$56.1K | |
| 2024-05-20 | 2024-05-16 | REPL | Replimune Group, Inc. | Sarchi Christopher | Chief Commercial Off | S - Sale | $6.47 | -2,218 | 92.3K | -2% | -$14.4K | |
| D | 2024-04-03 | 2024-04-01 | REPL | Replimune Group, Inc. | Sarchi Christopher | Chief Commercial Off | A - Grant | $0.00 | +22.2K | 94.5K | +31% | $0 |
| 2023-11-17 | 2023-11-16 | REPL | Replimune Group, Inc. | Sarchi Christopher | Chief Commercial Off | S - Sale | $10.92 | -5,255 | 72.2K | -7% | -$57.4K |
Purchase Sale Sale after option exercise All abbreviations